Journal of Medicinal Chemistry · 2009 · 10 citations · 9 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsChemical Space ExplorationHormonal TherapyLead Compound DesignLigand-based DesignSteroid PharmacologyBiological Activity FeaturesProgesterone PharmacologySubstituent Effects On Biological Activity
A series of mifepristone derivatives with different "linker groups" in position 4' of the phenyl ring in the 11beta-position of the steroid scaffold (2-41) have been synthesized. Their antigestagenic activites were determined in a cell-based assay (alkali phosphatase assay in T47-D breast cancer cells) and compared with that of the parent compound mifepristone. SAR and QSAR studies reveal the influence of both lipophilicity and partial charge based van der Waals surface area descriptors on biological activity. Within the series of compounds described in this study, three mifepristone derivatives are identified with considerably high antigestagenic activity. These compounds are regarded as useful starting materials for the synthesis of either physiologically stable or cleavable progesterone receptor-binding conjugates for therapeutic or diagnostic purposes.
9
Atomic structure of progesterone complexed with its receptor
Shawn P. Williams, Paul B. Sigler · Nature · 1998 · 666 citations
The pharmacological basis of therapeutics
Joy Davies · Occupational and Environmental Medicine · 2007 · 576 citations · Full text
Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function.
John P. Lydon, Gaoxiang Ge, Frances Kittrell et al. · PubMed · 1999 · 190 citations
Medicine, Endocrinology, Oncology +17